Teladoc Health, Inc.
0LDR.L
London Stock Exchange9.29
USD
+0.31
- -
Teladoc Health, Inc.
0LDR.L
(London Stock Exchange)
Recent
price
9.29
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Teladoc Health, Inc. Teladoc Health, Inc. (NYSE: TDOC) is a leading provider of virtual healthcare services, delivering telemedicine, integrated care platforms, and digital health solutions worldwide through brands including Teladoc, Livongo, and BetterHelp; its core offerings encompass general medical consultations, expert medical opinions, chronic condition management for diabetes and hypertension, mental health therapy via online counseling and text-based interactions, dermatology, primary care, AI-driven analytics, telehealth devices, and licensable enterprise platforms for hospitals and health systems. The company operates in approximately 130 countries, serving employers, health plans, hospitals, insurers, and individual members with on-demand remote care via telephone, videoconferencing, mobile apps, and enabling technologies that support point-of-care visits and clinical collaboration. Founded in 2002 and headquartered in Purchase, New York, Teladoc Health, Inc. divides its business into segments such as Integrated Care, featuring virtual medical services across specialties and chronic care, and BetterHelp, focused on direct-to-consumer mental health platforms. Recent strategic developments include the February 2025 acquisition of Catapult Health for $65 million to enhance at-home diagnostics and preventive care integration; the May 2025 purchase of Uplift for $30 million to expand insured mental health services through BetterHelp; and the August 2025 acquisition of Telecare, an Australian specialist and allied health provider, to strengthen international presence particularly in regional and remote areas, alongside deployments of virtual neonatology and telesurgery solutions in Australian hospitals.